221 related articles for article (PubMed ID: 32542696)
1. miR-448-3p alleviates diabetic vascular dysfunction by inhibiting endothelial-mesenchymal transition through DPP-4 dysregulation.
Guan GY; Wei N; Song T; Zhao C; Sun Y; Pan RX; Zhang LL; Xu YY; Dai YM; Han H
J Cell Physiol; 2020 Dec; 235(12):10024-10036. PubMed ID: 32542696
[TBL] [Abstract][Full Text] [Related]
2. Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition.
Shi S; Srivastava SP; Kanasaki M; He J; Kitada M; Nagai T; Nitta K; Takagi S; Kanasaki K; Koya D
Kidney Int; 2015 Sep; 88(3):479-89. PubMed ID: 25830763
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-142-3p inhibits high-glucose-induced endothelial-to-mesenchymal transition through targeting TGF-β1/Smad pathway in primary human aortic endothelial cells.
Zhu GH; Li R; Zeng Y; Zhou T; Xiong F; Zhu M
Int J Clin Exp Pathol; 2018; 11(3):1208-1217. PubMed ID: 31938215
[TBL] [Abstract][Full Text] [Related]
4. A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.
Du JK; Yu Q; Liu YJ; Du SF; Huang LY; Xu DH; Ni X; Zhu XY
Theranostics; 2021; 11(9):4207-4231. PubMed ID: 33754057
[No Abstract] [Full Text] [Related]
5. miR-222 inhibits cardiac fibrosis in diabetic mice heart via regulating Wnt/β-catenin-mediated endothelium to mesenchymal transition.
Wang Z; Wang Z; Gao L; Xiao L; Yao R; Du B; Li Y; Wu L; Liang C; Huang Z; Li P; Zhang Y
J Cell Physiol; 2020 Mar; 235(3):2149-2160. PubMed ID: 31389030
[TBL] [Abstract][Full Text] [Related]
6. miR-200b Mediates Endothelial-to-Mesenchymal Transition in Diabetic Cardiomyopathy.
Feng B; Cao Y; Chen S; Chu X; Chu Y; Chakrabarti S
Diabetes; 2016 Mar; 65(3):768-79. PubMed ID: 26718496
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cell metabolic memory causes cardiovascular dysfunction in diabetes.
Yao Y; Song Q; Hu C; Da X; Yu Y; He Z; Xu C; Chen Q; Wang QK
Cardiovasc Res; 2022 Jan; 118(1):196-211. PubMed ID: 33483741
[TBL] [Abstract][Full Text] [Related]
8. miR-200-3p suppresses cell proliferation and reduces apoptosis in diabetic retinopathy via blocking the TGF-β2/Smad pathway.
Xue L; Xiong C; Li J; Ren Y; Zhang L; Jiao K; Chen C; Ding P
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33150936
[TBL] [Abstract][Full Text] [Related]
9. P66Shc-Induced MicroRNA-34a Causes Diabetic Endothelial Dysfunction by Downregulating Sirtuin1.
Li Q; Kim YR; Vikram A; Kumar S; Kassan M; Gabani M; Lee SK; Jacobs JS; Irani K
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2394-2403. PubMed ID: 27789474
[TBL] [Abstract][Full Text] [Related]
10. MiR-18a-5p inhibits endothelial-mesenchymal transition and cardiac fibrosis through the Notch2 pathway.
Geng H; Guan J
Biochem Biophys Res Commun; 2017 Sep; 491(2):329-336. PubMed ID: 28733035
[TBL] [Abstract][Full Text] [Related]
11. Melatonin Attenuates Endothelial-to-Mesenchymal Transition of Glomerular Endothelial Cells via Regulating miR-497/ROCK in Diabetic Nephropathy.
Liu F; Zhang S; Xu R; Gao S; Yin J
Kidney Blood Press Res; 2018; 43(5):1425-1436. PubMed ID: 30212830
[TBL] [Abstract][Full Text] [Related]
12. T2DM inhibition of endothelial miR-342-3p facilitates angiogenic dysfunction via repression of FGF11 signaling.
Cheng S; Cui Y; Fan L; Mu X; Hua Y
Biochem Biophys Res Commun; 2018 Sep; 503(1):71-78. PubMed ID: 29852165
[TBL] [Abstract][Full Text] [Related]
13. miR302a-3p May Modulate Renal Epithelial-Mesenchymal Transition in Diabetic Kidney Disease by Targeting ZEB1.
Tang WB; Zheng L; Yan R; Yang J; Ning J; Peng L; Zhou Q; Chen L
Nephron; 2018; 138(3):231-242. PubMed ID: 29227974
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine Protects Against Kidney Fibrosis in Diabetic Mice by Targeting miR-101-3p-Mediated EndMT.
Song L; Feng S; Yu H; Shi S
Dose Response; 2022; 20(1):15593258221083486. PubMed ID: 35370507
[No Abstract] [Full Text] [Related]
15. Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen.
Kanasaki K; Shi S; Kanasaki M; He J; Nagai T; Nakamura Y; Ishigaki Y; Kitada M; Srivastava SP; Koya D
Diabetes; 2014 Jun; 63(6):2120-31. PubMed ID: 24574044
[TBL] [Abstract][Full Text] [Related]
16. Circular Noncoding RNA HIPK3 Mediates Retinal Vascular Dysfunction in Diabetes Mellitus.
Shan K; Liu C; Liu BH; Chen X; Dong R; Liu X; Zhang YY; Liu B; Zhang SJ; Wang JJ; Zhang SH; Wu JH; Zhao C; Yan B
Circulation; 2017 Oct; 136(17):1629-1642. PubMed ID: 28860123
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of endothelial to mesenchymal transition in the retina in diabetes.
Cao Y; Feng B; Chen S; Chu Y; Chakrabarti S
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7321-31. PubMed ID: 25335984
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA 9 Is a Regulator of Endothelial to Mesenchymal Transition in Diabetic Retinopathy.
Wang E; Feng B; Chakrabarti S
Invest Ophthalmol Vis Sci; 2023 Jun; 64(7):13. PubMed ID: 37279396
[TBL] [Abstract][Full Text] [Related]
19. Effect of Antifibrotic MicroRNAs Crosstalk on the Action of N-acetyl-seryl-aspartyl-lysyl-proline in Diabetes-related Kidney Fibrosis.
Srivastava SP; Shi S; Kanasaki M; Nagai T; Kitada M; He J; Nakamura Y; Ishigaki Y; Kanasaki K; Koya D
Sci Rep; 2016 Jul; 6():29884. PubMed ID: 27425816
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of miR-21 alleviated cardiac perivascular fibrosis via repressing EndMT in T1DM.
Li Q; Yao Y; Shi S; Zhou M; Zhou Y; Wang M; Chiu JJ; Huang Z; Zhang W; Liu M; Wang Q; Tu X
J Cell Mol Med; 2020 Jan; 24(1):910-920. PubMed ID: 31680453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
